Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 808731, 4 pages
http://dx.doi.org/10.1155/2013/808731
Research Article

Cardiac Safety of Diclofenac at a Single Dose in Ram

1Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, 42075 Konya, Turkey
2Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Dicle, 21280 Diyarbakir, Turkey
3Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Mehmet Akif Ersoy, 15030 Burdur, Turkey

Received 14 August 2013; Accepted 5 September 2013

Academic Editors: W. S. Aronow and H. Oguz

Copyright © 2013 Ayse Er et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kaya, “Nonsteroid antiinflamatuar drug,” in Pharmacology in Veterinary Medicine, S. Kaya, A. Bilgili, and I. Pirinçci, Eds., pp. 373–400, Medisan, Ankara, Turkey, 2002. View at Google Scholar
  2. EMEA, 2003, http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500013751&mid=WC0b01ac058008d7ad.
  3. T. J. Gan, “Diclofenac: an update on its mechanism of action and safety profile,” Current Medical Research and Opinion, vol. 26, no. 7, pp. 1715–1731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A.-M. S. Olsen, E. L. Fosbøl, J. Lindhardsen et al., “Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study,” Circulation, vol. 123, no. 20, pp. 2226–2235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Tras and M. Elmas, “Analgesic, antipyretic and anti-inflammatory drugs,” in Veterinary Drug, E. Yazar, Ed., pp. 209–233, Olgun-Celik Press, Konya, Turkey, 2012. View at Google Scholar
  6. W. A. Ray, C. H. Disease, C. Varas-Lorenzo et al., “Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious,” Circulation, vol. 2, no. 3, pp. 155–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. O'Malley, “The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice,” Clinical Nurse Specialist, vol. 20, no. 6, pp. 277–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Singh, O. Wu, P. Langhorne, and R. Madhok, “Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis,” Arthritis Research and Therapy, vol. 8, no. 5, article R153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. T. Cheetham, J. D. Graham, D. Campen et al., “Myocardial infarction and Its association with the use of nonselective NSAIDs: a nested case-control and time-to-event analsis,” The Permanente Journal, vol. 12, no. 1, pp. 16–22, 2008. View at Google Scholar
  10. M. Hermann, “Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs,” Current Rheumatology Reports, vol. 11, no. 1, pp. 31–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Krötz and L. Struthmann, “A review on the risk of myocardial infarction associated with the NSAID diclofenac,” Cardiovascular and Hematological Disorders, vol. 10, no. 1, pp. 53–65, 2010. View at Google Scholar · View at Scopus
  12. E. Yazar, V. Altunok, M. Elmas, B. Traş, A. L. Baş, and V. Özdemir, “Effect of tilmicosin on cardiac muscle and serum creatine kinases activities and serum total protein level in healthy male Balb/C mice,” Revue de Medecine Veterinaire, vol. 152, no. 12, pp. 881–883, 2001. View at Google Scholar · View at Scopus
  13. E. Yazar, Y. O. Birdane, M. Elmas, B. Traş, and A. L. Baş, “Effect of tilmicosin on serum creatine kinase, creatine kinase-MB and troponin I levels in New Zealand white rabbits,” Archiv für Geflügelkunde, vol. 66, no. 5, pp. 237–239, 2002. View at Google Scholar · View at Scopus
  14. A. Harrison and S. Amundson, “Evaluation and management of the acutely dyspneic patient: the role of biomarkers,” American Journal of Emergency Medicine, vol. 23, no. 3, pp. 371–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. O. D. Ekici and N. Isik, “Investigation of the cardiotoxicity of imidocarb in lambs,” Revue de Medecine Veterinaire, vol. 162, no. 1, pp. 40–44, 2011. View at Google Scholar · View at Scopus
  16. A. Er, F. Altan, G. Cetin, B. Dik, M. Elmas, and E. Yazar, “Assessment of the cardiotoxicity of tulathromycin in rabbits,” Acta Veterinaria Hungarica, vol. 59, no. 3, pp. 327–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Rahal, A. Kumar, A. H. Ahmad, and J. K. Malik, “Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep,” Research in Veterinary Science, vol. 84, no. 3, pp. 452–456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. O'Brien, “Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity,” Toxicology, vol. 245, no. 3, pp. 206–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Howie-Esquivel and M. White, “Biomarkers in acute cardiovascular disease,” Journal of Cardiovascular Nursing, vol. 23, no. 2, pp. 124–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Oudman, J. F. Clark, and L. M. Brewster, “The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review,” PLoS One, vol. 8, no. 1, Article ID e52879, 2013. View at Google Scholar
  21. M. Mahmod, I. F. Nor, and O. Maskon, “Acute myocardial infarction following ingestion of a non-selective non-steroidal anti-inflammatory drug,” BMJ Case Repots, 2010. View at Publisher · View at Google Scholar
  22. S. Özdemir, “Routine tests of the liver,” Nobel Medicus, vol. 5, no. 2, pp. 5–9, 2009. View at Google Scholar · View at Scopus
  23. E. V. Hersh, P. A. Moore, and G. L. Ross, “Over-the-counter analgesics and antipyretics: a critical assessment,” Clinical Therapeutics, vol. 22, no. 5, pp. 500–548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Duman and B. F. Erden, “Short reviews of biochemical laboratory data for primary health care,” Sted, vol. 13, no. 7, p. 256, 2004. View at Google Scholar
  25. D. Young, C. Peterson, C. Basch, and S. C. Halladay, “Effects of naproxen and nabumetone on serum cholesterol levels in patients with osteoarthritis,” Clinical Therapeutics, vol. 17, no. 2, pp. 231–240, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Zapolska-Downar and M. Naruszewicz, “A pleiotropic antiatherogenic action of ibuprofen,” Medical Science Monitor, vol. 7, no. 4, pp. 837–841, 2001. View at Google Scholar · View at Scopus
  27. M. Tauseef, M. Shahid, K. K. Sharma, and M. Fahim, “Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats,” Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 4, pp. 314–321, 2008. View at Publisher · View at Google Scholar · View at Scopus